v3 Template
P

Pharmaron Beijing Co., Limited

Life Sciences / Pharmaceutical ~150 employees
Founded
--
Employees (Est.)
~150
10 leaders known
Total Funding
$185.7M
Funding Rounds
1
Last Funding
2023-03-29

About Pharmaron Beijing Co., Limited

Pharmaron is a premier life science service provider and contract research and manufacturing organization (CRO/CDMO) that offers comprehensive research, development, and manufacturing services throughout the entire drug discovery, preclinical, clinical development, and commercialization process for small molecules, biologics, and cell & gene therapy products. Their mission is to support partners' success in discovering, developing, and commercializing innovative medicines.

Products & Services

Laboratory Services:Includes synthetic chemistry, medicinal chemistry, structural biology, in vitro and in vivo pharmacology, DMPK, safety assessment, and bioanalysis for drug discovery and development.
Chemistry, Manufacturing & Controls (CMC):Covers small molecule drug substance and product development, API and drug product manufacturing, analytical development, and quality assurance.
Clinical Development:Encompasses early phase clinical research, radiolabelled studies, human ADME, vaccine development, bioanalysis, and clinical trial recruitment in the US and China.
Biologics & Cell & Gene Therapy (CGT):Offers biologics laboratory services, antibody discovery, biologics CDMO, CGT laboratory services, and gene therapy manufacturing.
Medical Modalities:Includes services for small molecules, biologics, cell & gene therapies, antibody-drug conjugates (ADC) & bioconjugates, and protein degraders.

Specialties

Drug Discovery Preclinical and Clinical Development Contract Research and Manufacturing (CRO/CDMO) Small Molecules Biologics Cell & Gene Therapies Antibody-Drug Conjugates (ADC) Protein Degraders Radiolabelled Sciences Safety Assessment

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 185730000
MR: -
FA: £151m
FAN: 185730000
D: 2023-03-29
FD: 2023-03-29
1 investors
Grant Latest
2023-03-29
$185.7M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

B

Boliang Lou

CEO and Chairman

L

Larry Lou

President & COO

B

Bei Zheng

Executive Vice President

H

Hua Yang, Ph.D.

Chief Scientific Officer

G

Gilbert Li

Chief Financial Officer & Board Secretary

K

Katherine Lee

Chief Business Officer

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Pharmaron Beijing Co., Limited Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Life Sciences / Pharmaceutical
Company Size
~150 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro